Mort J S, Dodge G R, Roughley P J, Liu J, Finch S J, DiPasquale G, Poole A R
Joint Diseases Laboratory, Shriners Hospital for Crippled Children, Montreal, Quebec, Canada.
Matrix. 1993 Mar;13(2):95-102. doi: 10.1016/s0934-8832(11)80068-5.
When adult human articular cartilage was maintained in organ culture in the presence of interleukin 1 beta, increased destruction of the extracellular matrix was observed, as judged by increased type II collagen degradation in situ determined immunohistochemically and the increased release of proteoglycan into the culture medium. Concomitant with these changes was the increased release of latent metalloproteinases into the culture medium. Culture of cartilage in the presence of a peptidylhydroxamate metalloproteinase inhibitor indicated a key role for the active forms of these enzymes in situ, since it produced a marked reduction in both proteoglycan release and collagen degradation. This compound had no detectable cytotoxic effects in organ culture and did not reduce the secretion of the metalloproteinases. The results of this study provide direct evidence that the latent metalloproteinase precursors, whose release is greatly stimulated by interleukin 1, are indeed activated to some degree and participate in cartilage matrix degradation.
当在白细胞介素1β存在的情况下对成人关节软骨进行器官培养时,观察到细胞外基质的破坏增加,这是通过免疫组织化学测定原位II型胶原降解增加以及蛋白聚糖释放到培养基中的量增加来判断的。与这些变化同时发生的是,潜伏金属蛋白酶释放到培养基中的量增加。在肽基羟肟酸金属蛋白酶抑制剂存在的情况下对软骨进行培养表明,这些酶的活性形式在原位起关键作用,因为它使蛋白聚糖释放和胶原降解都显著减少。该化合物在器官培养中没有可检测到的细胞毒性作用,也没有减少金属蛋白酶的分泌。这项研究的结果提供了直接证据,即其释放受到白细胞介素1极大刺激的潜伏金属蛋白酶前体确实在一定程度上被激活并参与软骨基质降解。